|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/24 | |||
| A61P 37/00 | |||
| A61P 9/00 | |||
| A61P 9/12 |
| (11) | Number of the document | 2464370 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10808864.2 |
| Date of filing the European patent application | 2010-08-16 | |
| (97) | Date of publication of the European application | 2012-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/045605 |
| Date | 2010-08-16 |
| (87) | Number | WO 2011/020091 |
| Date | 2011-02-17 |
| (30) | Number | Date | Country code |
| 234151 P | 2009-08-14 | US |
| (72) |
SADEGHI, Homayoun, US
TURNER, Andrew, US
DAGHER, Suzanne, US
|
| (73) |
Phasebio Pharmaceuticals, Inc.,
One Great Valley Parkway Suite 30, Malvern, Pennsylvania 19355,
US
|
| (54) | MODIFIED VASOACTIVE INTESTINAL PEPTIDES |
| MODIFIED VASOACTIVE INTESTINAL PEPTIDES |